(WASHINGTON) — U.S. officials have approved another Alzheimer’s drug that can modestly slow the disease, providing a new option for patients in the early stages of the incurable, memory-destroying ailment. The Food and Drug Administration approved Eli Lilly’s Kisunla on Tuesday for mild or early cases of dementia caused by Alzheimer’s.
Fda Approves Second Alzheimer’s Drug That Can Modestly Slow Disease
MATTHEW PERRONE / AP, Time
Tue, 07/02/2024 - 11:37am
Topics: the food drug administration eli it&rsquo physicians ldquo;i’m dr suzanne schindler washington university louis diagnosing early is so important both kisunla japanese alzheimer s costs fda&rsquo the fda ldquo;certainly changing your diet lifestyle may slow down logistical biogen ldquo;those dr mark mintun the associated press health science department howard hughes medical institute&rsquo educational media group washington u.s alzheimer&rsquo the i in lilly&rsquo eisai lilly st read kisunla ap fda leqembi lilly s drugs plaque treatment month safety year’s worth levels reached doctors delay scans months based long reported
BING NEWS:
- FDA approves Alzheimer’s drug that can slow disease
U.S. officials have approved another Alzheimer’s drug that can modestly slow the disease, providing a new option for patients in the early stages of the incurable, memory-destroying ailment.
07/3/2024 - 11:15 pm | View Link - FDA approves a second Alzheimer’s drug that can modestly slow disease
U.S. health officials have approved a new Alzheimer’s drug that can modestly slow the disease. It's only the second drug that's been convincingly shown to slow the memory-destroying condition.
07/3/2024 - 4:06 am | View Link - FDA approves new Alzheimer’s treatment that slows decline in memory
The FDA approved a new Alzheimer’s drug that has been shown in clinical trials to modestly slow a decline in memory and thinking abilities.
07/3/2024 - 2:00 am | View Link - FDA approves second Alzheimer's drug to slow disease
U.S. officials have approved another Alzheimer’s drug that can modestly slow the disease, providing a new option for patients in the early stages of the incurable, memory-destroying ailment.
07/2/2024 - 5:00 pm | View Link - FDA approves Eli Lilly's Alzheimer's drug that can modestly slow disease
Eli Lilly's Kisunla is the second treatment available in the U.S. that has been shown in trials to modestly slow a decline in memory.
07/2/2024 - 9:04 am | View Link - More
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more